Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

Respir Res. 2020 Jan 28;21(1):29. doi: 10.1186/s12931-020-1304-7.

Kristina Krempaska^{1

2

3}, Sandra Barnowski^{1

2}, Jacopo Gavini⁴, Nina Hobi^{5

6}, Simone Ebener^{1

2}, Cedric Simillion^{2

7}, Andrea Stokes^{1

2}, Ronja Schliep⁸, Lars Knudsen^{8

9}, Thomas K Geiser^{1

2}, Manuela Funke-Chambour^{10

11}

¹ Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland.
² Department for BioMedical Research, University of Bern, Bern, Switzerland.
³ Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
⁴ Department of Visceral Surgery and Medicine, Department for BioMedical Research, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland.
⁵ AlveoliX AG, Murtenstrasse 50, 3008, Bern, Switzerland.
⁶ ARTORG Center for Biomedical Engineering Research, Organs-on-Chip Technologies, University of Bern, Bern, Switzerland.
⁷ Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland.
⁸ Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany.
⁹ Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany.
¹⁰ Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, CH-3010, Bern, Switzerland. manuela.funke-chambour@insel.ch.
¹¹ Department for BioMedical Research, University of Bern, Bern, Switzerland. manuela.funke-chambour@insel.ch.

Abstract

After publication of our article [1], we have been notified that an extra alpha symbol (α) was mistakenly added at the beginning of the title.